VIGNA, Elisa

VIGNA, Elisa  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 52 (tempo di esecuzione: 0.05 secondi).
Titolo Data di pubblicazione Autore(i) File
"Active" cancer immunotherapy by anti-Met antibody gene transfer 2008 Vigna E; Pacchiana G; Mazzone M; Chiriaco C; Fontani L; Basilico C; Pennacchietti S; Comoglio PM
A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. 1992 HARTMANN G ;NALDINI L ;WEIDNER KM ;SACHS M ;VIGNA E ;COMOGLIO PM ;BIRCHMEIER W
A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity. 2013 Olwill SA;Joffroy C;Gille H;Vigna E;Matschiner G;Allersdorfer A;Lunde BM;Jaworski J;Burrows JF;Chiriaco C;Christian HJ;Hülsmeyer M;Trentmann S;Jensen K;Hohlbaum AM;Audoly L
A receptor-antibody hybrid hampering MET-driven metastatic spread 2021 Modica C.; Basilico C.; Chiriaco C.; Borrelli N.; Comoglio P.M.; Vigna E.
Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes 2015 Valentina Sala;Simona Gallo;Stefano Gatti;Elisa Vigna;Antonio Ponzetto;Tiziana Crepaldi
Anti-met fab-fc for the treatment of a tumor and/or metastasis 2019 VIGNA ELISA; BASILICO CRISTINA; TIZIANA CREPALDI; COMOGLIO PAOLO MARIA
Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products 2007 COMOGLIO Paolo Maria; VIGNA Elisa; GIORDANO Silvia
Antibody Fragments, Compositions And Uses Thereof - granted patent (USA) 2019 Elisa Vigna; Paolo Michieli; Paolo Maria Comoglio
Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. 1995 NALDINI L ;VIGNA E ;BARDELLI A ;FOLLENZI A ;GALIMI F ;COMOGLIO PM
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib 2016 Sala, Valentina; Gallo, Simona; Gatti, Stefano; Medico, Enzo; Vigna, Elisa; Cantarella, Daniela; Fontani, Lara; Natale, Massimo; Cimino, James; Morello, Mara; Comoglio, Paolo Maria; Ponzetto, Antonio; Crepaldi, Tiziana
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells 2018 Leuci, V.; Casucci, G.M.; Grignani, G.; Rotolo, R.; Rossotti, U.; Vigna, E.; Gammaitoni, L.; Mesiano, G.; Fiorino, E.; Donini, C.; Pisacane, A.; ambrosio, L.D.; Pignochino, Y.; Aglietta, M.; Bondanza, A.; Sangiolo, D.
Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. 2005 Amendola M;Venneri MA;Biffi A;Vigna E;Naldini L
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma 2023 Giraudo, Lidia; Cattaneo, Giulia; Gammaitoni, Loretta; Iaia, Ilenia; Donini, Chiara; Massa, Annamaria; Centomo, Maria Laura; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Picciotto, Franco; Berrino, Enrico; Marchiò, Caterina; Merlini, Alessandra; Paruzzo, Luca; Poletto, Stefano; Caravelli, Daniela; Biolato, Andrea Michela; Bortolot, Valentina; Landoni, Elisa; Ventin, Marco; Ferrone, Cristina R; Aglietta, Massimo; Dotti, Gianpietro; Leuci, Valeria; Carnevale-Schianca, Fabrizio; Sangiolo, Dario
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes 2020 Leuci, Valeria; Donini, Chiara; Grignani, Giovanni; Rotolo, Ramona; Mesiano, Giulia; Fiorino, Erika; Gammaitoni, Loretta; D'Ambrosio, Lorenzo; Merlini, Alessandra; Landoni, Elisa; Medico, Enzo; Capellero, Sonia; Giraudo, Lidia; Cattaneo, Giulia; Iaia, Ilenia; Pignochino, Ymera; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Fagioli, Franca; Ferrone, Soldano; Aglietta, Massimo; Gianpietro, Dotti; Sangiolo, Dario
Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody 2016 Cignetto, Simona; Modica, Chiara; Chiriaco, Cristina; Fontani, Lara; Milla, Paola; Michieli, Paolo; Comoglio, Paolo M.; Vigna, Elisa
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy 2022 Chiriaco, Cristina; Donini, Chiara; Cortese, Marco; Ughetto, Stefano; Modica, Chiara; Martinelli, Ilaria; Proment, Alessia; Vitali, Letizia; Fontani, Lara; Casucci, Monica; Comoglio, Paolo Maria; Giordano, Silvia; Sangiolo, Dario; Leuci, Valeria; Vigna, Elisa
Efficient Tet-dependent expression of human factor IX in vivo by a new self-regulating lentiviral vector. 2005 Vigna E;Amendola M;Benedicenti F;Simmons AD;Follenzi A;Naldini L
Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor 2021 Desole C.; Gallo S.; Vitacolonna A.; Vigna E.; Basilico C.; Montarolo F.; Zuppini F.; Casanova E.; Miggiano R.; Ferraris D.M.; Bertolotto A.; Comoglio P.M.; Crepaldi T.
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. 1992 NALDINI L ;TAMAGNONE L ;VIGNA E ;SACHS M ;HARTMANN G ;BIRCHMEIER W ;DAIKUHARA Y ;TSUBOUCHI H ;BLASI F ;COMOGLIO PM
Genetic Ablation of the MET Oncogene Defines a Crucial Role of the HGF/MET Axis in Cell-Autonomous Functions Driving Tumor Dissemination 2023 Chiara Modica; Marco Cortese; Francesca Bersani; Andrea Maria Lombardi; Francesca Napoli; Luisella Righi; Riccardo Taulli; Cristina Basilico; Elisa Vigna